DSCLX | VFWPX | DSCLX / VFWPX | |
Total Expense Ratio | 0.27 | 0.03 | 900% |
Annual Report Gross Expense Ratio | 0.27 | 0.03 | 900% |
Fund Existence | 13 years | 15 years | - |
Gain YTD | 23.358 | 17.999 | 130% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.78B | 65.3B | 3% |
Annual Yield % from dividends | 3.09 | 2.76 | 112% |
Returns for 1 year | 23.18 | 14.33 | 162% |
Returns for 3 years | 59.16 | 39.17 | 151% |
Returns for 5 years | 75.11 | 44.42 | 169% |
Returns for 10 years | 74.23 | 51.33 | 145% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QABA | 57.49 | 0.53 | +0.93% |
First Trust NASDAQ® ABA Community Bk ETF | |||
BBP | 59.73 | 0.31 | +0.51% |
Virtus LifeSci Biotech Products ETF | |||
IBMQ | 25.41 | 0.03 | +0.12% |
iShares iBonds Dec 2028 Term Muni Bd ETF | |||
BSCP | 20.70 | 0.01 | +0.05% |
Invesco BulletShares 2025 Corp Bd ETF | |||
HBMBF | 204.00 | N/A | N/A |
HBM Bioventures AG |